GSK rejects $68.4bn Unilever bid for consumer health

GSK rejects $68.4bn Unilever bid for consumer health

Submitted by admin on January 17, 2022 - 10:47am
Source: 
Pharmaforum
News Tags: 
GSK
Unilever
consumer healthcare
M&A
Headline: 
GSK rejects $68.4bn Unilever bid for consumer health
snippet: 

GlaxoSmithKline (GSK) claims it has rejected three unsolicited, conditional and non-binding proposals from Unilever to acquire GSK Consumer Healthcare in a deal worth approximately $68.4 billion (£50 billion).

Do Not Allow Advertisers to Use My Personal information